Search hospitals > Florida > Jacksonville
Clinical Neuroscience Solutions, Inc
Claim this profileJacksonville, Florida 32256
Global Leader in Depression
Global Leader in Major Depressive Disorder
Conducts research for Attention Deficit Hyperactivity Disorder (ADHD)
Conducts research for Attention-Deficit/Hyperactivity Disorder (ADHD)
Conducts research for Ventricular Hyperkinesia
186 reported clinical trials
4 medical researchers
Summary
Clinical Neuroscience Solutions, Inc is a medical facility located in Jacksonville, Florida. This center is recognized for care of Depression, Major Depressive Disorder, Attention Deficit Hyperactivity Disorder (ADHD), Attention-Deficit/Hyperactivity Disorder (ADHD), Ventricular Hyperkinesia and other specialties. Clinical Neuroscience Solutions, Inc is involved with conducting 186 clinical trials across 101 conditions. There are 4 research doctors associated with this hospital, such as Nandita Jones, Nandita Joshi Jones, John Joyce, and John Mark Joyce.Top PIs
Nandita JonesClinical Neuroscience Solutions, Inc. dba CNS Healthcare4 years of reported clinical research
Studies Vestibular Migraine
Studies Migraine
8 reported clinical trials
6 drugs studied
Nandita Joshi JonesClinical Neuroscience Solutions Inc5 years of reported clinical research
Studies Migraine
Studies Neonatal Hyperkinesia
5 reported clinical trials
5 drugs studied
John JoyceClinical Neuroscience Solutions, Inc3 years of reported clinical research
Studies Depression
Studies Major Depressive Disorder
3 reported clinical trials
6 drugs studied
John Mark JoyceCNS Healthcare - Jacksonville3 years of reported clinical research
Studies Alzheimer's Disease
Studies Depression
2 reported clinical trials
3 drugs studied
Clinical Trials running at Clinical Neuroscience Solutions, Inc
Depression
Major Depressive Disorder
Vestibular Migraine
Migraine
Alzheimer's Disease
COVID-19
Obesity
Major Depression
Coronavirus
Attention-Deficit/Hyperactivity Disorder (ADHD)
MM120
for Depression
A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating MM120 Compared to Placebo in Major Depressive Disorder - Emerge
Recruiting2 awards Phase 33 criteria
Psilocybin
for Depression
Safety, Tolerability, pharmacokinetics and efficacy of a single administration of COMP360 in participants with recurrent Major Depressive Disorder.
Recruiting1 award Phase 26 criteria
Azetukalner
for Depression
X-NOVA2 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of azetukalner as a monotherapy in adult participants diagnosed with Major Depressive Disorder (MDD)
Recruiting1 award Phase 35 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Clinical Neuroscience Solutions, Inc?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.